E-LIB Suche - Ergebnisse für: Tesař, Vladimír

1

WCN24-2506 IMMUNOSUPPRESSIVE THERAPY IS NOT ASSOCIATED WITH..:

Myslivecek, Marek ; Bednarova, Vladimira ; Peiskerova, Martina..
Kidney International Reports. 9 (2024) 4 - p. S609 , 2024

Link: https://doi.org/10.1016/..

2

Proliferative glomerulonephritis with monoclonal IgG deposi..:

Svabova, Eva ; Zieg, Jakub ; Sukova, Martina...
Pediatric Nephrology. , 2024

Link: https://doi.org/10.1007/..

3

Corrigendum to "Executive summary of the KDIGO 2024 Clinica..:

Floege, Jürgen ; Jayne, David R.W. ; Sanders, Jan-Stephan F....
Kidney International. 106 (2024) 1 - p. 163-164 , 2024

Link: https://doi.org/10.1016/..

4

WCN24-1674 NEFECON TREATMENT RESPONSE IN ASIAN AND WHITE PA..:

Barratt, Jonathan ; Kristensen, Jens ; Stone, Andrew...
Kidney International Reports. 9 (2024) 4 - p. S169-S170 , 2024

Link: https://doi.org/10.1016/..

5

A novel dosing approach for rituximab in glomerular disease..:

Hartinger, Jan Miroslav ; Šíma, Martin ; Hrušková, Zdenka...
Biomedicine & Pharmacotherapy. 175 (2024) - p. 116655 , 2024

Link: https://doi.org/10.1016/..

6

Targeted-release budesonide modifies key pathogenic biomark..:

Wimbury, David ; Muto, Masahiro ; Bhachu, Jasraj S....
Kidney International. 105 (2024) 2 - p. 381-388 , 2024

Link: https://doi.org/10.1016/..

7

Computable phenotype for real-world, data-driven retrospect..:

Scott, Jennifer ; White, Arthur ; Walsh, Cathal...
RMD Open. 10 (2024) 2 - p. e003962 , 2024

Link: https://doi.org/10.1136/..

8

WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WI..:

Barratt, Jonathan ; Kristensen, Jens ; Stone, Andrew...
Kidney International Reports. 9 (2024) 4 - p. S174 , 2024

Link: https://doi.org/10.1016/..

9

WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR P..:

Barratt, Jonathan ; Kristensen, Jens ; Stone, Andrew...
Kidney International Reports. 9 (2024) 4 - p. S174-S175 , 2024

Link: https://doi.org/10.1016/..

10

WCN24-1294 ATACICEPT REDUCES HEMATURIA AND SERUM GD-IGA1, B..:

Barratt, Jonathan ; Maes, Bart ; Lin, Celia...
Kidney International Reports. 9 (2024) 4 - p. S158 , 2024

Link: https://doi.org/10.1016/..

11

WCN24-2509 RETROSPECTIVE HISTOPATHOLOGICAL ANALYSIS OF FIBR..:

Kollar, Marek ; Hruskova, Zdenka ; Kratky, Vojtech...
Kidney International Reports. 9 (2024) 4 - p. S195 , 2024

Link: https://doi.org/10.1016/..

12

WCN24-871 HIGH-OUTPUT HEART FAILURE AMONG PATIENTS ON CHRON..:

Malik, Jan ; Valerianova, Anna ; Salajova, Kristina Buryskova...
Kidney International Reports. 9 (2024) 4 - p. S84-S85 , 2024

Link: https://doi.org/10.1016/..

13

A phase 2b, randomized, double-blind, placebo-controlled, c..:

Lafayette, Richard ; Barbour, Sean ; Israni, Rubeen...
Kidney International. 105 (2024) 6 - p. 1306-1315 , 2024

Link: https://doi.org/10.1016/..

14

Corrigendum to "KDIGO 2024 Clinical Practice Guideline for ..:

Floege, Jürgen ; Jayne, David R.W. ; Sanders, Jan-Stephan F...
Kidney International. 106 (2024) 1 - p. 160-163 , 2024

Link: https://doi.org/10.1016/..

15

WCN24-1414 ORIGIN 3: PIVOTAL PHASE 3 STUDY EVALUATING EFFEC..:

Barratt, Jonathan ; Maes, Bart ; Israni, Rubeen...
Kidney International Reports. 9 (2024) 4 - p. S164 , 2024

Link: https://doi.org/10.1016/..